Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-12,671
Closed -$1.7M 94
2025
Q3
$1.7M Hold
12,671
0.24% 73
2025
Q2
$1.72M Buy
+12,671
New +$1.67M 0.24% 73
2024
Q1
Sell
-3,309
Closed -$364K 136
2023
Q4
$364K Sell
3,309
-202
-6% -$20.2K 0.07% 69
2023
Q3
$340K Sell
3,511
-6,185
-64% -$650K 0.07% 70
2023
Q2
$1.06M Sell
9,696
-10,666
-52% -$1.14M 0.19% 61
2023
Q1
$2.06M Sell
20,362
-1,121
-5% -$118K 0.3% 57
2022
Q4
$2.36M Buy
21,483
+5,579
+35% +$578K 0.37% 53
2022
Q3
$1.54M Buy
+15,904
New +$1.7M 0.26% 69
2021
Q4
Sell
-7,552
Closed -$892K 173
2021
Q3
$892K Buy
7,552
+678
+10% +$83.3K 0.11% 93
2021
Q2
$796K Sell
6,874
-79
-1% -$9.21K 0.1% 86
2021
Q1
$833K Buy
6,953
+1,229
+21% +$146K 0.1% 82
2020
Q4
$626K Buy
5,724
+4,699
+458% +$511K 0.08% 84
2020
Q3
$112K Buy
+1,025
New +$104K 0.02% 90
2019
Q2
Sell
-3,134
Closed -$251K 130
2019
Q1
$251K Buy
3,134
+934
+42% +$69.5K 0.14% 30
2018
Q4
$159K Buy
+2,200
New +$155K 0.07% 43

Other funds holding ABT

Mirova's ABT Position: Q4 2025 in Review

Mirova sold out of Abbott (ABT) in Q4 2025, closing a stake of 12,671 shares — an estimated $1.7M sold.

Mirova first reported a position in ABT in Q4 2018 and held it in 15 quarters. The position peaked at $2.36M in Q4 2022. 3,284 funds tracked by Wall St. Rank hold ABT as of Q4 2025.

  • Mirova reported no remaining Abbott position as of Q4 2025 after selling out during the quarter.
  • Mirova sold 12,671 Abbott shares in Q4 2025, an estimated $1.7M.
  • Mirova first reported a position in Abbott in Q4 2018 and held it in 15 quarters.
  • Mirova's Abbott position peaked at $2.36M in Q4 2022.
  • 3,284 funds tracked by Wall St. Rank held Abbott as of Q4 2025.

Based on Mirova's 13F filing for Q4 2025, filed 13 Feb 2026.